Some studies have demonstrated a link between the decreased expression of IDO at the maternal–fetal interface and various adverse pregnancy outcomes, including recurrent spontaneous abortion (RSA) and preeclampsia [37, 38]. Here, IDO1 is linked to spontaneous abortion.